Fig 1.
A: Changes in the absorption maximum of the congo red-polysaccharide complex at various concentrations of sodium hydroxide solution; B: HPTLC analysis for monosaccharide composition of the polysaccharide. L1: L-Arabinose L2: D-Fructose, L3: D-Fucose, L4: D-Galactose, L5: Polysacchaide, L6: D-Glucose, L7: D-Mannose, L8: D-Rhamnose, L9: D-Xylose; C: GC-MS of five standard monosaccharides and D: GC-MS of polysaccharide from P. flabellatus.
Fig 2.
From left, dispersed and exfoliated graphene oxide, aqueous solution of the polysaccharide, polysaccharide-reduced graphene oxide.
Fig 3.
DLS elucidation of the synthesized PR-GO.
Fig 4.
TEM image of PR-GO.
Fig 5.
XRD spectrum of PR-GO nanosheets.
Fig 6.
EDX spectrum of PR-GO nanosheets.
Fig 7.
Fourier transform infrared spectra of (a) PR-GO; (b) Crude polysaccharide and (c) GO.
Fig 8.
Raman Spectrum of PRGO (Curve A) and GO (Curve B).
Fig 9.
Cytotoxicity of PR-GO in terms of MTT, Resazurin and neutral red uptakeassays.
Fig 10.
Flow cytometry and confocal microscopy of human PBMC treated with different concentrations of PR-GO.
Fig 11.
Genotoxic effects of different concentrations of PR-GO on human PBMCs.
Fig 12.
ROS generation in human PBMCs induced by PR-GO.